NIH-funded research R21 grant

Understanding how the immune system responds to Staphylococcus aureus infections

Official title: Host-driven antibody responses against Staphylococcus aureus

Funded at University of Chicago · NIH-11137735 · Data updated 2026-11-12

This study is looking at how our immune system fights off infections from a common germ called Staphylococcus aureus, which can cause serious skin and blood infections, to help find ways to create better vaccines for people at risk.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startJuly 12, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$205,000
NIH project number5R21AI181332-02
Project IDNIH-11137735 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced recurrent Staphylococcus aureus infections or are at high risk for such infections.

Less likely to help

Patients who do not have a history of Staphylococcus aureus infections or those with other unrelated health conditions may not benefit from this research.

What this research studies

This research investigates how the immune system, specifically antibody responses, reacts to infections caused by Staphylococcus aureus, a common bacterium that can lead to serious skin and bloodstream infections. The study focuses on identifying protective antigens that could help develop effective vaccines against this pathogen. By using mouse models, the researchers will explore the role of specific immune cells and antibodies in controlling and preventing these infections. The findings aim to enhance our understanding of immune responses and improve treatment strategies for patients affected by Staphylococcus aureus.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective vaccines or therapies that enhance the immune response against Staphylococcus aureus infections.

How similar studies have gone: Previous research has shown promise in understanding immune responses to bacterial infections, but this specific approach to targeting Staphylococcus aureus is relatively novel.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Golovkina, Tatyana V — University of Chicago
  • Study coordinator: Golovkina, Tatyana V

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.